Drug­mak­ers to Mary­land af­ford­abil­i­ty board: Cap­ping list prices may not help pa­tients

Drug­mak­ers are push­ing back against Mary­land’s Pre­scrip­tion Drug Af­ford­abil­i­ty Board and its list of six med­i­cines that will be re­viewed for po­ten­tial price caps. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER